|
Scynexis, Inc. (SCYX) DCF -Bewertung |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
SCYNEXIS, Inc. (SCYX) Bundle
Entdecken Sie das wahre Potenzial von Scynexis, Inc. (SCYX) mit unserem fortschrittlichen DCF -Taschenrechner! Passen Sie wesentliche Annahmen an, erkunden Sie verschiedene Szenarien und bewerten Sie die Auswirkungen von Änderungen auf die Bewertung von Scynexis, Inc. (SCYX) - alles bequem innerhalb einer einzelnen Excel -Vorlage.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .0 | 13.2 | 5.1 | 140.1 | 3.7 | 3.2 | 2.7 | 2.3 | 2.0 | 1.7 |
| Revenue Growth, % | 0 | 0 | -61.32 | 2652.72 | -97.33 | -14.66 | -14.66 | -14.66 | -14.66 | -14.66 |
| EBITDA | -51.1 | -31.4 | -59.9 | 73.5 | -20.3 | -.9 | -.8 | -.7 | -.6 | -.5 |
| EBITDA, % | 100 | -238.65 | -1176.76 | 52.43 | -542.15 | -29.51 | -29.51 | -29.51 | -29.51 | -29.51 |
| Depreciation | .3 | .6 | .8 | .8 | .0 | .8 | .7 | .6 | .5 | .4 |
| Depreciation, % | 100 | 4.38 | 15.97 | 0.57799 | 0 | 24.19 | 24.19 | 24.19 | 24.19 | 24.19 |
| EBIT | -51.5 | -32.0 | -60.7 | 72.7 | -20.3 | -.9 | -.8 | -.7 | -.6 | -.5 |
| EBIT, % | 100 | -243.04 | -1192.73 | 51.85 | -542.15 | -29.63 | -29.63 | -29.63 | -29.63 | -29.63 |
| Total Cash | 93.0 | 104.5 | 73.5 | 74.4 | 16.1 | 2.9 | 2.5 | 2.1 | 1.8 | 1.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2.9 | .9 | 2.1 | 21.8 | .0 | 1.0 | .9 | .8 | .6 | .6 |
| Account Receivables, % | 100 | 6.54 | 41.27 | 15.57 | 0 | 32.68 | 32.68 | 32.68 | 32.68 | 32.68 |
| Inventories | 1.9 | .5 | .9 | .0 | .0 | .8 | .7 | .6 | .5 | .4 |
| Inventories, % | 100 | 3.52 | 17.66 | 0 | 0 | 24.24 | 24.24 | 24.24 | 24.24 | 24.24 |
| Accounts Payable | 4.6 | 7.8 | 5.9 | 7.1 | 4.6 | 2.3 | 2.0 | 1.7 | 1.4 | 1.2 |
| Accounts Payable, % | 100 | 59.62 | 116.62 | 5.1 | 121.97 | 72.94 | 72.94 | 72.94 | 72.94 | 72.94 |
| Capital Expenditure | .0 | -1.2 | .0 | .0 | .0 | -.1 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 100 | -8.9 | -0.17678 | 0 | 0 | -1.82 | -1.82 | -1.82 | -1.82 | -1.82 |
| Tax Rate, % | -0.71439 | -0.71439 | -0.71439 | -0.71439 | -0.71439 | -0.71439 | -0.71439 | -0.71439 | -0.71439 | -0.71439 |
| EBITAT | -48.7 | -29.2 | -56.5 | 72.5 | -20.5 | -.9 | -.8 | -.7 | -.6 | -.5 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -48.5 | -23.2 | -59.3 | 55.7 | -1.2 | -4.2 | -.2 | -.2 | -.2 | -.1 |
| WACC, % | 10.18 | 10.14 | 10.16 | 10.25 | 10.26 | 10.2 | 10.2 | 10.2 | 10.2 | 10.2 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | -2 | |||||||||
| Present Terminal Value | -1 | |||||||||
| Enterprise Value | -6 | |||||||||
| Net Debt | 0 | |||||||||
| Equity Value | -6 | |||||||||
| Diluted Shares Outstanding, MM | 49 | |||||||||
| Equity Value Per Share | -0.12 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real SCYNEXIS financials.
- Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effects of your inputs on SCYNEXIS’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Comprehensive Data: SCYNEXIS, Inc.'s historical financial statements and pre-filled projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: Observe SCYNEXIS, Inc.'s intrinsic value recalculating instantly.
- Visual Data Representation: Dashboard charts illustrate valuation outcomes and essential metrics.
- Designed for Precision: A sophisticated tool for analysts, investors, and finance professionals.
How It Works
- Download the Template: Gain immediate access to the Excel-based SCYNEXIS, Inc. (SCYX) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates SCYNEXIS, Inc.'s (SCYX) intrinsic value.
- Test Scenarios: Experiment with various assumptions to see how they affect potential valuation outcomes.
- Analyze and Decide: Utilize the results to inform your investment or financial analysis decisions.
Why Choose This Calculator for SCYNEXIS, Inc. (SCYX)?
- All-in-One Solution: Combines DCF, WACC, and comprehensive financial ratio analyses tailored for SCYNEXIS.
- Flexible Inputs: Modify yellow-highlighted fields to explore different financial scenarios for SCYX.
- In-Depth Analysis: Automatically computes SCYNEXIS’s intrinsic value and Net Present Value.
- Integrated Data: Historical and projected data provide reliable starting points for analysis.
- Expert-Level Tool: Suited for financial analysts, investors, and consultants focusing on SCYNEXIS, Inc. (SCYX).
Who Should Use This Product?
- Individual Investors: Make informed decisions about buying or selling SCYNEXIS, Inc. (SCYX) stock.
- Financial Analysts: Streamline valuation processes with ready-to-use financial models for SCYNEXIS, Inc. (SCYX).
- Consultants: Deliver professional valuation insights on SCYNEXIS, Inc. (SCYX) to clients quickly and accurately.
- Business Owners: Understand how biotech companies like SCYNEXIS, Inc. (SCYX) are valued to guide your own strategy.
- Finance Students: Learn valuation techniques using real-world data and scenarios related to SCYNEXIS, Inc. (SCYX).
What the Template Contains
- Pre-Filled DCF Model: SCYNEXIS, Inc.’s (SCYX) financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital specific to SCYNEXIS.
- Financial Ratios: Assess SCYNEXIS’s profitability, leverage, and efficiency metrics.
- Editable Inputs: Modify assumptions such as growth rates, margins, and CAPEX to suit your scenarios.
- Financial Statements: Annual and quarterly reports to facilitate in-depth analysis of SCYNEXIS.
- Interactive Dashboard: Effortlessly visualize key valuation metrics and results for SCYNEXIS.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.